ERDAFITINIB vs ERLOTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ERDAFITINIB vs ERLOTINIB: Safety Overview
| Metric | ERDAFITINIB | ERLOTINIB |
|---|---|---|
| Total FAERS Reports | 1,106 | 22,472 |
| Deaths Reported | 315 | 6,791 |
| Death Rate | 28.5% | 30.2% |
| Hospitalizations | 226 | 3,693 |
| Average Patient Age | 66.6 yrs | 67.2 yrs |
| % Female Patients | 37.9% | 59.8% |
| FDA Approval Date | Apr 12, 2019 | Apr 16, 2020 |
| Manufacturer | Janssen Products LP | Zydus Lifesciences Limited |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Discontinued |